CIP
ARNA

Convergence Investment Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Convergence Investment Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-23,535
Closed -$1.08M – 332
2019
Q3 		$1.08M Buy
23,535
+19,717
+516% +$1.11M 0.3% 125
2019
Q2 		$224K Buy
+3,818
New +$197K 0.05% 229

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Convergence Investment Partners's ARNA Position: Q4 2019 in Review

Convergence Investment Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 23,535 shares — an estimated $1.08M sold.

Convergence Investment Partners first reported a position in ARNA in Q2 2019 and held it in 2 quarters. The position peaked at $1.08M in Q3 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • Convergence Investment Partners reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 23,535 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $1.08M.
  • Convergence Investment Partners first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 2 quarters.
  • Convergence Investment Partners's Arena Pharmaceuticals Inc position peaked at $1.08M in Q3 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Convergence Investment Partners's 13F filing for Q4 2019, filed 22 Jan 2020.